All News

What you need to know about the FDA’s most recent novel drug approvals.

After a bad 2017 season, pharmacies and the FDA are pushing the public to still get flu vaccines.

This peer-reviewed article will show you what you need to know about the latest breakthroughs and treatment options.

FDA approves lofexidine for opioid withdrawal symptoms.

From productivity to relaxation, these apps can help you be better at everything you do.

There are a lot of factors that go into medication errors-pharmacists are stepping up, but the FDA must also act.

A new FDA plan will offer new education opportunities for a variety of healthcare workers.

Our annual pick of the worst states to practice pharmacy in America is back with the 2018 results.

Pharmacists add value, but you need to show that to health-system executives.

The opioid epidemic requires that all healthcare professionals-pharmacists included-re-examine how they approach pain patients.

Why one pharmacist thinks pharmacy education is being wasted.

Drug errors generally fall into one of four categories-here's how the experts say those errors can be eliminated. 

Memorizing reams of drug names and information is tough, but this pharmacist has some tricks to help you out. 

A massive retrospective study compared several non-vitamin K antagonist oral anticoagulants (NOACs) to warfarin.

Tall man lettering is supposed to help reduce medication errors-but some say it doesn’t go far enough.

The September Small Doses brings you the latest news that affects pharmacists.

Stopping medication errors in a busy pharmacy isn't an easy fix, but steps must be taken to lessen a serious problem.

Why pharmacists need to be paying attention to the Trinity II case and its consequences.

The FDA recently approved cannabidiol oral solution to treat seizures.

Stalled competition hurts consumers and may keep prices higher.

1.1 million Americans live with HIV-here’s how you can help.

How pharmacists can help students get the treatments they need.

Information is a patient’s greatest ally, but it’s no help if they can’t understand it.

Drug Topics recently spoke with the FDA about the role pharmacists can play in patient education.

The EpiPen shortage is putting lives at risk and creating a back-up at some pharmacies. But solutions are on the horizon.

The annual report on generic access and savings shows some impressive numbers for 2017.